冠状动脉支架置入术后双重抗血小板治疗的持续时间：缺血与出血之间的最佳平衡点在哪里？ - Suppr

Suppr

超能文献

Duration of dual antiplatelet therapy after coronary artery stenting: where is the sweet spot between ischaemia and bleeding?

作者信息

Binder Ronald K, Lüscher Thomas F

机构信息

Editorial Office, European Heart Journal, Zurich Heart House, Careum Campus, Moussonstreet 4, Zurich 8091, Switzerland.

Editorial Office, European Heart Journal, Zurich Heart House, Careum Campus, Moussonstreet 4, Zurich 8091, Switzerland

出版信息

Eur Heart J. 2015 May 21;36(20):1207-11. doi: 10.1093/eurheartj/ehv103. Epub 2015 Apr 2.

DOI:10.1093/eurheartj/ehv103

PMID:25838437

Abstract

摘要

相似文献

Duration of dual antiplatelet therapy after coronary artery stenting: where is the sweet spot between ischaemia and bleeding?冠状动脉支架置入术后双重抗血小板治疗的持续时间：缺血与出血之间的最佳平衡点在哪里？

Eur Heart J. 2015 May 21;36(20):1207-11. doi: 10.1093/eurheartj/ehv103. Epub 2015 Apr 2.

Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).支架置入术后联合西洛他唑与氯吡格雷双倍剂量治疗：HOST-ASSURE 随机试验（优化药物洗脱支架治疗策略以确保安全性和有效性及抗血小板方案的冠状动脉狭窄的协调性研究）。

JACC Cardiovasc Interv. 2013 Sep;6(9):932-42. doi: 10.1016/j.jcin.2013.04.022.

Clinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: a meta-analysis of randomized trials.药物洗脱支架时代经皮冠状动脉介入治疗后延长双联抗血小板治疗的临床影响：随机试验的荟萃分析。

Eur Heart J. 2012 Dec;33(24):3078-87. doi: 10.1093/eurheartj/ehs318. Epub 2012 Oct 22.

Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specified analysis from the PRODIGY (Prolonging Dual-Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) trial.接受支架植入后 6 或 24 个月双抗血小板治疗的患者临床特征对缺血和出血结局的影响：来自 PRODIGY（评价支架内内膜增生后延长双联抗血小板治疗）试验的预先指定分析。

Eur Heart J. 2015 May 21;36(20):1242-51. doi: 10.1093/eurheartj/ehv038. Epub 2015 Feb 25.

Prognostic implications of early and long-term bleeding events in patients on one-year dual antiplatelet therapy following drug-eluting stent implantation.药物洗脱支架置入术后一年接受双联抗血小板治疗患者的早期和长期出血事件的预后意义。

Catheter Cardiovasc Interv. 2012 Sep 1;80(3):395-405. doi: 10.1002/ccd.23337. Epub 2012 Jan 10.

Risk and management of upper gastrointestinal bleeding associated with prolonged dual-antiplatelet therapy after percutaneous coronary intervention.经皮冠状动脉介入治疗后长期双联抗血小板治疗相关上消化道出血的风险与管理

Cardiovasc Revasc Med. 2009 Jan-Mar;10(1):36-44. doi: 10.1016/j.carrev.2008.11.001.

[Role of bare metal stent in drug eluting stent era].[裸金属支架在药物洗脱支架时代的作用]

Nihon Rinsho. 2011 Feb;69(2):265-70.

Combining warfarin and antiplatelet therapy after coronary stenting in the Global Registry of Acute Coronary Events: is it safe and effective to use just one antiplatelet agent?在全球急性冠状动脉事件注册研究中，冠状动脉支架置入术后联合使用华法林和抗血小板治疗：仅使用一种抗血小板药物是否安全有效？

Eur Heart J. 2007 Jul;28(14):1717-22. doi: 10.1093/eurheartj/ehm186. Epub 2007 Jun 11.

ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting.ISAR-SAFE 研究：药物洗脱支架置入后氯吡格雷治疗 6 个月与 12 个月的随机、双盲、安慰剂对照临床试验

Eur Heart J. 2015 May 21;36(20):1252-63. doi: 10.1093/eurheartj/ehu523. Epub 2015 Jan 23.

Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials.药物洗脱支架置入术后接受延长双联抗血小板治疗患者的死亡率：随机试验的成对和贝叶斯网状荟萃分析。

Lancet. 2015 Jun 13;385(9985):2371-82. doi: 10.1016/S0140-6736(15)60263-X. Epub 2015 Mar 14.

引用本文的文献

Shortened Duration of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Contemporary Clinical Review.经皮冠状动脉介入治疗后双联抗血小板治疗疗程的缩短：一项当代临床综述

Interv Cardiol. 2023 Dec 11;18:e31. doi: 10.15420/icr.2023.19. eCollection 2023.

Development of a risk score for predicting the benefit versus harm of extending dual antiplatelet therapy beyond 6 months following percutaneous coronary intervention for stable coronary artery disease.开发一种风险评分模型，以预测在经皮冠状动脉介入治疗（PCI）治疗稳定型冠状动脉疾病后，将双联抗血小板治疗（DAPT）延长至 6 个月以上的获益与危害。

PLoS One. 2019 Feb 14;14(2):e0209661. doi: 10.1371/journal.pone.0209661. eCollection 2019.

The effect of cessation of 2nd generation PY inhibitor therapy on platelet reactivity in patients 1 year after acute myocardial infarction.急性心肌梗死后 1 年停止第二代 P2Y12 抑制剂治疗对血小板反应性的影响。

J Thromb Thrombolysis. 2018 Oct;46(3):351-358. doi: 10.1007/s11239-018-1701-7.

Application of Feedback System Control Optimization Technique in Combined Use of Dual Antiplatelet Therapy and Herbal Medicines.反馈系统控制优化技术在双联抗血小板治疗与草药联合应用中的应用

Front Physiol. 2018 May 4;9:491. doi: 10.3389/fphys.2018.00491. eCollection 2018.

Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention or after acute coronary syndrome : Practical lessons from a review.经皮冠状动脉介入治疗或急性冠状动脉综合征后双联抗血小板治疗的最佳持续时间：一项综述的实践经验

Neth Heart J. 2017 Dec;25(12):655-663. doi: 10.1007/s12471-017-1023-y.

Cost-effectiveness analysis of 30-month vs 12-month dual antiplatelet therapy with clopidogrel and aspirin after drug-eluting stents in patients with acute coronary syndrome.急性冠状动脉综合征患者药物洗脱支架置入术后，氯吡格雷与阿司匹林联合应用30个月与12个月双联抗血小板治疗的成本效益分析。

Clin Cardiol. 2017 Oct;40(10):789-796. doi: 10.1002/clc.22756. Epub 2017 Jul 6.

Efficacy and safety of short-term (≤6 months) duration of dual antiplatelet therapy after drug-eluting stents: a meta-analysis of randomized controlled trials.药物洗脱支架植入术后短期（≤6个月）双联抗血小板治疗的疗效与安全性：一项随机对照试验的荟萃分析

Anatol J Cardiol. 2017 Mar;17(3):168-175. doi: 10.14744/AnatolJCardiol.2016.7285. Epub 2016 Nov 10.

Very very late stent thrombosis: 9.5 years after DES implantation.极晚期支架血栓形成：药物洗脱支架植入9.5年后。

Indian Heart J. 2016 Sep;68 Suppl 2(Suppl 2):S39-S43. doi: 10.1016/j.ihj.2016.01.018. Epub 2016 Feb 11.

Diagnosis and Management of Cardiovascular Disease in Advanced and End-Stage Renal Disease.晚期及终末期肾病患者心血管疾病的诊断与管理

J Am Heart Assoc. 2016 Aug 4;5(8):e003648. doi: 10.1161/JAHA.116.003648.

Nanotechnology in diagnosis and treatment of coronary artery disease.纳米技术在冠状动脉疾病诊断与治疗中的应用

Nanomedicine (Lond). 2016;11(5):513-30. doi: 10.2217/nnm.16.3. Epub 2016 Feb 23.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验